4-aminopyridine has been researched along with Epileptiform Neuralgia in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effect of dalfampridine (4-aminopyridine), a broad-spectrum, voltage-dependent potassium channel blocker, on patients with trigeminal nerve dysfunction due to multiple sclerosis (MS)." | 3.80 | Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis. ( Birnbaum, G; Iverson, J, 2014) |
| "Trigeminal neuralgia is a paroxysmal disorder with severely disabling facial pain and thus continues to be a real therapeutic challenge." | 1.36 | [BK(Ca) channel agonist NS1619 and Kv channel antagonist 4-AP on the facial mechanical pain threshold in a rat model of chronic constriction injury of the infraorbital nerve]. ( Li, N; Liu, CY; Ma, B; Zhao, YF, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnbaum, G | 1 |
| Iverson, J | 1 |
| Montcuquet, A | 1 |
| Magy, L | 1 |
| Liu, CY | 1 |
| Li, N | 1 |
| Zhao, YF | 1 |
| Ma, B | 1 |
3 other studies available for 4-aminopyridine and Epileptiform Neuralgia
| Article | Year |
|---|---|
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Topics: 4-Aminopyridine; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Potassium Channel Blockers; | 2014 |
[Recurrence and de novo trigeminal neuralgia induced by fampridine].
Topics: 4-Aminopyridine; Adult; Aged; Female; Humans; Multiple Sclerosis; Recurrence; Trigeminal Neuralgia | 2015 |
[BK(Ca) channel agonist NS1619 and Kv channel antagonist 4-AP on the facial mechanical pain threshold in a rat model of chronic constriction injury of the infraorbital nerve].
Topics: 4-Aminopyridine; Animals; Benzimidazoles; Constriction; Facial Pain; Injections, Intralesional; Kv1. | 2010 |